Evoke Pharma (EVOK) Misses Q1 EPS by 51c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.51). Revenue for the quarter came in at $3.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Bessent: U.S. will enforce 'zero leakage' approach to Iran sanctions
• Carney on Trump's latest tariff threat: not a surprise U.S. would take some form of reprisal
• Bessent announces campaign to cut Iran from global economy